Table 4 Multivariable Cox proportional hazard model predicting BCR by adding 4 markers to SOC
From: Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer
Variable | HR | 95% CI | P value |
|---|---|---|---|
Pathological T stage (T3 vs T2) | 2.81 | 1.49–5.30 | 0.001 |
Gleason sum (4 + 3/8 − 10 vs 3 + 3/3 + 4) | 5.57 | 3.25–9.56 | < 0.001 |
Surgical margin (Pos vs neg) | 1.27 | 0.62–2.57 | 0.511 |
PA-18:0–22:0 (Low vs high) | 2.49 | 1.30–4.79 | 0.006 |
Apolipoprotein A-IV (High vs low) | 2.21 | 1.15–4.24 | 0.017 |
Tenascin C (High vs low) | 0.99 | 0.56–1.73 | 0.966 |
1-Methyladenosine (high vs low) | 2.11 | 1.14–3.92 | 0.017 |